Logo
x

Search

Subscribe Now

initiates

TG Therapeutics Initiates Patient Enrolment in P-III ULTRA-V Trial for Triple Combination Regimen to Treat R/R Chronic Lymphocytic Leukemia

TG Therapeutics Initiates Patient Enrolment in P-III ULTRA-V Trial for Triple Combination Regimen to Treat R/R Chronic Lymphocytic...

  • April 22, 2021
Daiichi Sankyo Initiates P-II Trial of Pexidartinib for Tenosynovial Giant Cell Tumor in Japan

Daiichi Sankyo Initiates P-II Trial of Pexidartinib for Tenosynovial Giant Cell Tumor in Japan

  • April 12, 2021
Evotec and Exscientia Initiate Human Clinical Trials of their Novel Immuno-Oncology Drug

Evotec and Exscientia Initiate Human Clinical Trials of their Novel Immuno-Oncology Drug

  • April 9, 2021
Tetra Bio-Pharma Initiates Additional Studies of ARDS-003 in Neuroinflammation and Antiviral Diseases

Tetra Bio-Pharma Initiates Additional Studies of ARDS-003 in Neuroinflammation and Antiviral Diseases

  • March 26, 2021
Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12

Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12

  • March 26, 2021
GSK Initiates P-III Study of GSK3511294 (GSK'294) for the Treatment of Severe Asthma

GSK Initiates P-III Study of GSK3511294 (GSK'294) for the Treatment of Severe Asthma

  • March 18, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.